Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minneapolis Heart Institute (MHI) is a world-renowned cardiovascular center based in Minneapolis, Minnesota, and is a key component of the Allina Health system. Working in tandem with the Minneapolis Heart Institute Foundation (MHIF), an independent nonprofit research and education organization, MHI is a global leader in the development and testing of innovative cardiovascular therapies and medical devices. The institute is renowned for its expertise in structural heart disease, interventional cardiology, and advanced heart failure management, including heart transplantation. With a robust portfolio of over 230 active clinical trials, MHI and MHIF are at the forefront of pioneering treatments such as transcatheter valve replacements and minimally invasive cardiac repairs. The organization serves as a major hub for cardiovascular education and clinical research, significantly impacting the standard of care for heart disease worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minneapolis Heart Center.